Santa Cruz, CA, United States of America

John J Stankus

USPTO Granted Patents = 6 


Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Santa Cruz, CA (US) (2023 - 2024)
  • San Jose, CA (US) (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by John J Stankus in Minimally Invasive Treatments

Introduction

John J Stankus is a notable inventor based in Santa Cruz, CA (US), recognized for his contributions to medical technology. He holds a total of five patents, focusing primarily on minimally invasive treatment methods for benign prostatic hyperplasia (BPH). His work aims to improve patient outcomes through innovative medical devices and formulations.

Latest Patents

Stankus's latest patents include an "Apparatus for treating Benign Prostatic Hyperplasia," which outlines minimally invasive treatment methods for BPH tissue. This system features a sustained release formulation that comprises a cytostatic or cytotoxic drug. It also includes an applicator or delivery system designed for the local delivery of the sustained release formulation to the prostate. The applicator is characterized by a KIR value of between 40 and 400 Centipoise per unit area. Another significant patent is titled "Treatments for benign prostatic hyperplasia," which shares similar features and aims to enhance the effectiveness of BPH treatments.

Career Highlights

Stankus has made significant strides in the field of medical technology through his innovative patents. His work has been instrumental in developing new treatment options for patients suffering from BPH, showcasing his commitment to improving healthcare solutions.

Collaborations

Some of his notable coworkers include Olof Mikael Trollsas and Shahram Shawn Gholami, who have collaborated with him on various projects within the medical technology sector.

Conclusion

John J Stankus continues to be a driving force in the development of minimally invasive treatments for benign prostatic hyperplasia. His innovative patents reflect his dedication to advancing medical technology and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…